NCT02646553

Brief Summary

Cortisol overproduction ( Cushings syndrome) is a condition where the patient have a special fat distribution, with accumulation of fat around the abdomen and in the neck, with thinner limbs and weak musculature. The condition can be difficult to separate from adipositas in general. Screening for hypercortisolism in adults has been easier the last years, because we can measure free cortisol in saliva samples at late night. In children we still dont have reference ranges for saliva cortisol in children, so the screening is still troublesome, based on Collection of 24-hour urine.The meaning of this study is to establish reference ranges for saliva cortisol, and evaluate in a cohort with adipose children if screening with saliva cortisol is sensitive and specific enough to be the New screening test for hypercortisolism in children too.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2012

Completed
3.7 years until next milestone

First Submitted

Initial submission to the registry

January 4, 2016

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 5, 2016

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

August 16, 2017

Status Verified

August 1, 2017

Enrollment Period

6.9 years

First QC Date

January 4, 2016

Last Update Submit

August 14, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of patients with positive saliva cortisol measurement, not having Cushings syndrome.

    Number of patients

    2 years

  • Number of patients With negative saliva cortisol measurement , having Cushings syndrome.

    Number of patients

    2 years

Study Arms (1)

Children refered to the obesity clinic.

All children refered to the obesity clinic for examination and optionally treatment are invited.

Other: Children refered to the obesity clinic

Interventions

Compere if urine cortisol is as good as saliva cortisol as a screening for hypercortisolism in children.

Children refered to the obesity clinic.

Eligibility Criteria

Age4 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The reference are made from healthy children included from kindergarden and Schools in the Bergen area. The age range from 4 to 16 years ols. The patient population is children refered to the obestity clinic at Haukeland University Hospital.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haukeland University Hospital

Bergen, 5021, Norway

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

the investigators collect saliva and urine from the patients, for analysis of the hormone cortisol.

MeSH Terms

Conditions

ACTH Syndrome, Ectopic

Condition Hierarchy (Ancestors)

Paraneoplastic Endocrine SyndromesParaneoplastic SyndromesNeoplasms

Study Officials

  • Grethe Åstrøm Ueland, MD

    Haukeland University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Grethe Åstrøm Ueland, MD

CONTACT

Gunnar Mellgren, Prof.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 4, 2016

First Posted

January 5, 2016

Study Start

May 1, 2012

Primary Completion

April 1, 2019

Study Completion

April 1, 2019

Last Updated

August 16, 2017

Record last verified: 2017-08

Locations